PRMT5 INHIBITORS

The invention relates to substituted nucleoside analogues of formula (I), pharmaceutically acceptable salts thereof and pharmaceutical compositions for treating diseases, disorders or conditions associated with the overexpression of PRMT5 enzyme. The invention also relates to methods of treating dis...

Full description

Saved in:
Bibliographic Details
Main Authors NAIR, PRATHAP, SREEDHARAN, PALLE, VENKATA, P, KAMBOJ, RAJENDER, KUMAR, TRYAMBAKE, MAHADEO, BHASKAR, KULKARNI, CHAITANYA, PRABHAKAR, GUDADE, GANESH, BHAUSAHEB, PAWAR, CHETAN, SANJAY, LAGAD, DIPAK, RAYCHAND, SINDKHEDKAR, MILIND, DATTATRAYA
Format Patent
LanguageEnglish
Serbian
Published 31.01.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to substituted nucleoside analogues of formula (I), pharmaceutically acceptable salts thereof and pharmaceutical compositions for treating diseases, disorders or conditions associated with the overexpression of PRMT5 enzyme. The invention also relates to methods of treating diseases, disorders or conditions associated with the overexpression of PRMT5 enzyme.
Bibliography:Application Number: RSP20231219